Terms: = Kidney tumors AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Prognosis
30 results:
1. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse prognosis and Unfavorable Response to Antiangiogenic Therapy.
Larrinaga G; Valdivia A; Arrieta-Aguirre I; Solano-Iturri JD; Ugalde-Olano A; Loizaga-Iriarte A; Santos-Martín A; Pérez-Fernández A; Angulo JC; López JI
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338778
[TBL] [Abstract] [Full Text] [Related]
2. ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through calr-mediated apoptosis.
Yu G; Gao J; Hu W; Hu D; Wang W; Yang S; Gao J
Sci Rep; 2023 Sep; 13(1):15687. PubMed ID: 37735575
[TBL] [Abstract] [Full Text] [Related]
3. Enhancing information on stage at diagnosis for childhood cancer in Africa.
Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
[TBL] [Abstract] [Full Text] [Related]
4. Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma.
Zhou S; Lu Y; Chen Y; Gan W
Sci Rep; 2023 Mar; 13(1):4449. PubMed ID: 36932108
[TBL] [Abstract] [Full Text] [Related]
5. Establishment and Validation of a Machine Learning Prediction Model Based on Big Data for Predicting the Risk of Bone Metastasis in Renal Cell Carcinoma Patients.
Xu C; Liu W; Yin C; Li W; Liu J; Sheng W; Tang H; Li W; Zhang Q
Comput Math Methods Med; 2022; 2022():5676570. PubMed ID: 36226243
[TBL] [Abstract] [Full Text] [Related]
6. [Clinicopathological features and prognosis of fumarate hydratase deficient renal cell carcinoma].
Yu YF; He SM; Wu YC; Xiong SW; Shen Q; Li YY; Yang F; He Q; Li XS
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):640-646. PubMed ID: 34393221
[TBL] [Abstract] [Full Text] [Related]
7. Preoperative anaemia and thrombocytosis predict adverse prognosis in non-metastatic renal cell carcinoma with tumour thrombus.
Xiao R; Xu C; He W; Liu L; Zhang H; Liu C; Ma L
BMC Urol; 2021 Feb; 21(1):31. PubMed ID: 33639914
[TBL] [Abstract] [Full Text] [Related]
8. [Clinicopathological features of hybrid oncocytic/chromophobe renal cell tumor].
Wang Y; Chong DC; Xin FJ; He B; Liu XL; Li YJ; Zhang W; Jiang YX
Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):97-102. PubMed ID: 33535302
[No Abstract] [Full Text] [Related]
9. Differential diagnosis of renal oncocytoma and chromophobe renal cell carcinoma using CT features: a central scar-matched retrospective study.
Li X; Nie P; Zhang J; Hou F; Ma Q; Cui J
Acta Radiol; 2022 Feb; 63(2):253-260. PubMed ID: 33497276
[TBL] [Abstract] [Full Text] [Related]
10. [Clinicopathological features and differential diagnosis of eosionphilic chromophobe renal cell carcinoma].
Zhang W; Song TT; He B; Wang H; Kang EH; Yu WJ; Zhong DC; Jiang YX; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2020 Dec; 49(12):1242-1248. PubMed ID: 33287507
[No Abstract] [Full Text] [Related]
11. Histological differential diagnostics of renal oncocytoma.
Baranovska VV; Romanenko АМ; Zakhartseva LM
Exp Oncol; 2020 Sep; 42(3):233-237. PubMed ID: 32996740
[TBL] [Abstract] [Full Text] [Related]
12. Distinguishing Benign Renal tumors with an Oncocytic Gene Expression (ONEX) Classifier.
McGillivray PD; Ueno D; Pooli A; Mendhiratta N; Syed JS; Nguyen KA; Schulam PG; Humphrey PA; Adeniran AJ; Boutros PC; Shuch B
Eur Urol; 2021 Jan; 79(1):107-111. PubMed ID: 32972793
[TBL] [Abstract] [Full Text] [Related]
13. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
An J; Park CK; Kim M; Joo JW; Cho NH
Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
[TBL] [Abstract] [Full Text] [Related]
14. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.
Leow JJ; Chong YL; Chang SL; Valderrama BP; Powles T; Bellmunt J
Eur Urol; 2021 May; 79(5):635-654. PubMed ID: 32798146
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of the SPOP mutant genomic subclass in prostate cancer.
Shoag J; Liu D; Ma X; Oromendia C; Christos P; Ballman K; Angulo C; Cai PY; Gaffney C; Klein E; Karnes J; Den RB; Liu Y; Davicioni E; Barbieri CE
Urol Oncol; 2020 May; 38(5):418-422. PubMed ID: 32192889
[TBL] [Abstract] [Full Text] [Related]
16. Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis.
Wu H; Fan L; Liu H; Guan B; Hu B; Liu F; Hocher B; Yin L
Biomed Res Int; 2020; 2020():4030915. PubMed ID: 31998788
[TBL] [Abstract] [Full Text] [Related]
17. Small-cell variant renal oncocytoma: Case report on its clinicopathological and genetic characteristics and literature review.
Li K; Wang C; Xiong X; Ma H; Qi Y; Hu W; Xiao S; Zhou X; Pang L; Zou H
Gene; 2020 Mar; 730():144266. PubMed ID: 31809837
[TBL] [Abstract] [Full Text] [Related]
18. Sporadic renal hybrid oncocytic/chromophobe tumor in a young man: A case report.
Hou B; Liang C
Medicine (Baltimore); 2019 Aug; 98(33):e16641. PubMed ID: 31415358
[TBL] [Abstract] [Full Text] [Related]
19. Case report of a combined oncocytoma and type 1 papillary renal cell carcinoma: a rare entity.
Gaeta R; Tognetti A; Kauffmann EF; Pollina LE
Pathologica; 2019 Mar; 111(1):37-40. PubMed ID: 31217621
[TBL] [Abstract] [Full Text] [Related]
20. Renal hybrid oncocytic/chromophobe tumor associated with multiple schwannomas: Case report and literature review.
Liu G; Li Y; Li Z; Zhou J; Huo Z; Ji Z
Medicine (Baltimore); 2017 Dec; 96(48):e8939. PubMed ID: 29310387
[TBL] [Abstract] [Full Text] [Related]
[Next]
